Abstract:The ever-growing drug resistance problem worldwide highlights the urgency to discover and develop new drugs. Microbial natural products are a prolific source of drugs. Genome sequencing has revealed a tremendous amount of uncharacterized natural product biosynthetic gene clusters (BGCs) encoded within microbial genomes, most of which are cryptic or express at very low levels under standard culture conditions. Therefore, developing effective strategies to awaken these cryptic BGCs is of great interest for natural product discovery. In this study, we designed and validated a Transcription–Translation in One (TTO) approach for activation of cryptic BGCs. This approach aims to alter the metabolite profiles of target strains by directly overexpressing exogenous rpsL (encoding ribosomal protein S12) and rpoB (encoding RNA polymerase β subunit) genes containing beneficial mutations for natural product production using a plug-and-play plasmid system. As a result, this approach bypasses the tedious screening work and overcomes the false positive problem in the traditional ribosome engineering approach. In this work, the TTO approach was successfully applied to activating cryptic BGCs in three Streptomyces strains, leading to the discovery of two aromatic polyketide antibiotics, piloquinone and homopiloquinone. We further identified a single BGC responsible for the biosynthesis of both piloquinone and homopiloquinone, which features an unusual starter unit incorporation step. This powerful strategy can be further exploited for BGC activation in strains even beyond streptomycetes, thus facilitating natural product discovery research in the future.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acschembio.0c00581?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschembio.0c00581</a>.Methods and materials, including strains, plasmids, chemicals, strain manipulation, cultivation and fermentation conditions, isolation and characterization of natural products from activated biosynthetic pathways, bioactivity assay, genome sequencing, gene overexpression and gene deletions (<a class="ext-link" href="/doi/suppl/10.1021/acschembio.0c00581/suppl_file/cb0c00581_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Activation of Cryptic Antibiotic Biosynthetic Gene Clusters Guided by RNA-seq Data from Both Streptomyces Ansochromogenes and ΔwblA

Activation and mechanism of a cryptic oviedomycin gene cluster via the disruption of a global regulatory gene, adpA, in Streptomyces ansochromogenes

Identification of Novel Mureidomycin Analogues Via Rational Activation of a Cryptic Gene Cluster in Streptomyces Roseosporus NRRL 15998.

An intricate regulation of WblA controlling production of silent tylosin analogues and abolishment of expressible nikkomycin

Co-expression of a pair of interdependent regulators coding genes ovmZ and ovmW awakens the production of angucyclinones antibiotics in Streptomyces neyagawaensis

A Versatile Transcription–Translation in One Approach for Activation of Cryptic Biosynthetic Gene Clusters

Wbla , a Pleiotropic Regulatory Gene Modulating Morphogenesis and Daptomycin Production in Streptomyces Roseosporus

Activation of a plasmid-situated type III PKS gene cluster by deletion of a wbl gene in deepsea-derived Streptomyces somaliensis SCSIO ZH66

Identification of novel tylosin analogues generated by a wblA disruption mutant of Streptomyces ansochromogenes

Activating a Cryptic Ansamycin Biosynthetic Gene Cluster to Produce Three New Naphthalenic Octaketide Ansamycins with N-Pentyl and N-Butyl Side Chains

Activation of Anthrachamycin Biosynthesis in Streptomyces Chattanoogensis L10 by Site-Directed Mutagenesis of Rpob

Activation and Characterization of Lanthomicins A–C by Promoter Engineering in Streptomyces chattanoogensis L10

Recent Advances in Strategies for Activation and Discovery/Characterization of Cryptic Biosynthetic Gene Clusters in Streptomyces

New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters

Identification and Characterization of the Anti-Methicillin-resistant Staphylococcus Aureus WAP-8294A2 Biosynthetic Gene Cluster from Lysobacter Enzymogenes OH11.

Overproduction of Ristomycin A by Activation of a Silent Gene Cluster in Amycolatopsis japonicum MG417-CF17

OSMAC-Based Discovery and Biosynthetic Gene Clusters Analysis of Secondary Metabolites from Marine-Derived Streptomyces globisporus SCSIO LCY30

Genome mining-directed activation of a silent angucycline biosynthetic gene cluster in Streptomyces chattanoogensis.

Recent advances in activating silent biosynthetic gene clusters in bacteria

Activating natural product synthesis using CRISPR interference and activation systems in Streptomyces